Immunosuppressive Agents
- 30 October 1994
- journal article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 74 (5) , 1029-1054
- https://doi.org/10.1016/s0039-6109(16)46432-7
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993
- Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejectionInflammation Research, 1991
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal AllograftsNew England Journal of Medicine, 1990
- CyclosporineNew England Journal of Medicine, 1989
- The use of the murine chronic graft Vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discoveryInflammation Research, 1987
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal TransplantationNew England Journal of Medicine, 1979